ADM announced the acquisition of Yerbalatina Phytoactives, a pioneering natural plant-based extracts and ingredients manufacturer.
“ADM is a global leader in nutrition, and we are proud to be at the cutting edge of many of today’s trends, including those toward fortified foods, beverages and supplements that enhance health and come from natural sources. Today, we’re adding to our ability to meet those important needs for our customers,” said Vikram Luthar, president of ADM’s Health & Wellness business.
He added that Yerbalatina’s wide array of natural botanical extracts — including organic-certified ingredients — combined with their R&D capabilities and market expertise, are exciting additions to ADM’s pantry as the company continues to build their leadership position in science-based microbiome solutions for human and animal health.
Based in Brazil, Yerbalatina uses proprietary cool-drying technology to transform fruits, vegetables and other plants – such as acerola, acai, guarana and green coffee – into a wide variety of extracts and ingredients for customers in the food, beverage and health industries. Its range of more than 100 botanical products and solutions includes functional nutrition and health ingredients; organic food colorings; organic powdered fruits; organic vegetable milks; and organic nutritional extracts.
“More and more consumers are turning to foods and supplements to help enhance health and wellness, and we are continuing to build a leadership position in that important market segment,” said Vince Macciocchi, president of ADM’s Nutrition business.
The global retail market for foods, beverages and supplements that support health & wellness is estimated at USD750bn and growing. “From prebiotics and probiotics to enzymes, botanical extracts, and nutritional oils, the breadth and depth of ADM’s expertise and portfolio ensure that our customers have everything they need to lead in this space. The addition of Yerbalatina represents yet another tool in our portfolio as we continue to unlock the power of nature to enrich the quality of life,” Maccioncchi underlined.
This acquisition expands ADM’s already significant business in Brazil. ADM also made public its timeline of recent ADM Health & Wellness growth investments, including the acquisition of Biopolis and the collaboration with Mayo Clinic in 2017, the acquisition of Protexin, the joint development agreement with Vland Biotech and new enzyme lab in Davis, California, in 2018.